{PDF} The Textbook of Pharmaceutical Medicine, 7th Edition

The Textbook of Pharmaceutical Medicine is the standard reference for everyone working and learning in pharmaceutical medicine. It is a comprehensive resource covering the processes and practices by which medicines are developed, tested and approved, and the recognised text for the Diploma in Pharmaceutical Medicine from the Faculty of Pharmaceutical Medicine.

This fully revised Seventh Edition, which includes two new Editors, encompasses current developments within pharmaceutical medicine with new chapters on biological therapeutics, pharmacovigilance, vaccines, drugs for cancer, drug development in paediatrics and neonatalogy, the clinical trials directive, life cycle management of medicines, counterfeit medicines and medical marketing. Also included for easy reference, and referred to throughout the text, are the Declaration of Helsinki, Guidelines and Documentation for Implementation of Clinical Trials, relevant European Directives and the Syllabus for Pharmaceutical Medicine.

Written by an international team of leading academics, medical directors and lawyers, The Textbook of Pharmaceutical Medicine, Seventh Edition meets the needs of both those working in pharmaceutical medicine and preparing for the Diploma in Pharmaceutical Medicine.

The text breaks down into three core sections:

Part I: Research and Development
Part II: Regulation
Part III: Healthcare marketplace

View Table of Contents in detail
Content:
Chapter 1 Discovery of New Medicines (pages 1?31): Yves J. Ribeill
Chapter 2 Pharmaceutical Development (pages 32?41): Michael Gamlen and Paul Cummings
Chapter 3 Preclinical Safety Testing (pages 42?81): Lutz Muller and Elisabeth Husar
Chapter 4 Exploratory Development (pages 82?112): John Posner
Chapter 5 Clinical Pharmacokinetics (pages 113?131): Paul Rolan and Valeria Molnar
Chapter 6 Biological Therapeutics (pages 132?142): Peter Lloyd and Jennifer Sims
Chapter 7 Objectives and Design of Clinical Trials (pages 143?154): John Posner and Steve Warrington
Chapter 8 Conduct of Clinical Trials: Good Clinical Practice (pages 155?188): Kate L. R. Darwin
Chapter 9 Medical Statistics (pages 189?218): Andrew P. Grieve
Chapter 10 Development of Medicines: Full Development (pages 219?234): Peter D. Stonier
Chapter 11 Pharmacovigilance (pages 235?253): Stephen F. Hobbiger, Bina Patel and Elizabeth Swain
Chapter 12 Vaccines (pages 254?269): John Beadle
Chapter 13 Drugs for Cancer (pages 270?285): James Spicer and Johann De Bono
Chapter 14 Ethics of Human Experimentation (pages 286?294): Jane Barrett
Chapter 15 Drug Development in Paediatrics and Neonatology (pages 295?305): Nazakat M. Merchant and Denis V. Azzopardi
Chapter 16 Due Diligence and the Role of the Pharmaceutical Physician (pages 306?315): Geoffrey R. Barker
Chapter 17 A History of Drug Regulation in the UK (pages 317?346): John P. Griffin
Chapter 18 The Clinical Trials Directive (pages 347?359): Fergus Sweeney and Agnes Saint Raymond
Chapter 19 Human Medicinal Products in the European Union: Regulations, Directives and Structures (pages 360?378): Agnes Saint Raymond and Anthony J. Humphreys
Chapter 20 Human Medicinal Products in the European Union: Procedures (pages 379?417): Agnes Saint Raymond and Anthony J. Humphreys
Chapter 21 European Regulation of Medical Devices (pages 418?434): Shuna Mason
Chapter 22 Paediatric Regulation (pages 435?446): Heike Rabe and Agnes Saint?Raymond
Chapter 23 Technical Requirements for Registration of Pharmaceuticals for Human Use: The ICH Process (pages 447?460): Dean W. G. Harron
Chapter 24 The Regulation of Drug Products by the US Food and Drug Administration (pages 461?500): Peter Barton Hutt
Chapter 25 The US FDA in the Drug Development, Evaluation and Approval Process (pages 501?517): Richard N. Spivey, Judith K. Jones, William Wardell and William W. Vodra
Chapter 26 Future Prospects of the Pharmaceutical Industry and its Regulation in the USA (pages 518?536): Richard N. Spivey, William W. Vodra, Judith K. Jones and William Wardell
Chapter 27 Regulatory and Clinical Trial Systems in Japan (pages 537?553): Mamiko Satake and Natsuko Hosoda
Chapter 28 The Regulation of Therapeutic Products in Australia (pages 554?586): Elizabeth de Somer, Deborah Monk and Janice Hirshorn
Chapter 29 An Introduction to Life Cycle Management of Medicines (pages 587?596): David Gillen
Chapter 30 Availability of Medicines Online and Counterfeit Medicines (pages 597?609): Ruth Diazaraque and David Gillen
Chapter 31 The Supply of Unlicensed Medicines for Individual Patient Use (pages 610?631): Ian Dodds?Smith and Ewan Townsend
Chapter 32 Legal and Ethical Issues Relating to Medicinal Products (pages 632?652): Nick Beckett, Sarah Hanson and Shuna Mason
Chapter 33 Medical Marketing (pages 653?669): David B. Galloway and Bensita M. V. Thottakam
Chapter 34 Information and Promotion (pages 670?691): Charles De Wet
Chapter 35 Economics of Health Care (pages 692?706): Carole A. Bradley and Jane R. Griffin
Chapter 36 Controls on NHS Medicines Prescribing and Expenditure in the UK (a Historical Perspective) with some International Comparisons (pages 707?727): John P. Griffin and Geoffrey R. Barker
Chapter 37 Pharmaceutical Medicine in the Emerging Markets (pages 728?743): Nadarajah Sreeharan, Jennie A. Sykes and Richard B. Nieman
Chapter 38 Biosimilars (pages 744?750): Raymond A. Huml and John Posner